Oppenheimer & Co’s Artivion AORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-13,072
Closed -$354K 1196
2019
Q4
$354K Buy
+13,072
New +$321K 0.01% 966
2018
Q4
Sell
-21,848
Closed -$769K 1246
2018
Q3
$769K Hold
21,848
0.02% 687
2018
Q2
$608K Hold
21,848
0.02% 787
2018
Q1
$438K Hold
21,848
0.01% 899
2017
Q4
$418K Buy
21,848
+2,693
+14% +$53.9K 0.01% 929
2017
Q3
$435K Buy
19,155
+500
+3% +$10.1K 0.01% 892
2017
Q2
$372K Buy
18,655
+818
+5% +$14.7K 0.01% 937
2017
Q1
$297K Buy
17,837
+2,997
+20% +$52.9K 0.01% 1003
2016
Q4
$285K Buy
14,840
+1,250
+9% +$22.8K 0.01% 1012
2016
Q3
$239K Buy
+13,590
New +$206K 0.01% 1066

Other funds holding AORT

Oppenheimer & Co's AORT Position: Q1 2020 in Review

Oppenheimer & Co sold out of Artivion (AORT) in Q1 2020, closing a stake of 13,072 shares — an estimated $354K sold.

Oppenheimer & Co first reported a position in AORT in Q3 2016 and held it in 10 quarters. The position peaked at $769K in Q3 2018. 126 funds tracked by Wall St. Rank hold AORT as of Q1 2020.

  • Oppenheimer & Co reported no remaining Artivion position as of Q1 2020 after selling out during the quarter.
  • Oppenheimer & Co sold 13,072 Artivion shares in Q1 2020, an estimated $354K.
  • Oppenheimer & Co first reported a position in Artivion in Q3 2016 and held it in 10 quarters.
  • Oppenheimer & Co's Artivion position peaked at $769K in Q3 2018.
  • 126 funds tracked by Wall St. Rank held Artivion as of Q1 2020.

Based on Oppenheimer & Co's 13F filing for Q1 2020, filed 8 May 2020.